- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/90 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Patent holdings for IPC class C07D 211/90
Total number of patents in this class: 189
10-year publication summary
9
|
7
|
9
|
10
|
9
|
11
|
8
|
10
|
10
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 4880 |
14 |
Nihon Nohyaku Co., Ltd. | 327 |
6 |
The Johns Hopkins University | 5675 |
5 |
Adeka Corporation | 1365 |
5 |
Hybrid Medical, LLC | 9 |
5 |
California Institute of Technology | 3977 |
4 |
CJ Cheiljedang Corporation | 3426 |
4 |
Kyushu University, National University Corporation | 1654 |
4 |
Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. | 6 |
4 |
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
3 |
Taisho Pharmaceutical Co., Ltd. | 875 |
3 |
C4 Theraprutics, Inc. | 56 |
3 |
Hefei Beini Medical Technology Company, Ltd | 4 |
3 |
Ice Bioscience Inc. | 3 |
3 |
Hybrid Medical, Inc. | 3 |
3 |
FUJIFILM Corporation | 29437 |
2 |
Board of Regents, The University of Texas System | 5808 |
2 |
University of South Florida | 1834 |
2 |
ABAC Therapeutics S.L. | 7 |
2 |
Alphora Research Inc. | 25 |
2 |
Other owners | 110 |